Skip to main content

Peer Review reports

From: Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer

Original Submission
4 Apr 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
27 Jul 2016 Editorially accepted
2 Aug 2016 Article published 10.1186/s12885-016-2636-z

You can find further information about peer review here.

Back to article page